Volume 1 Issue 1
2017-12-18 Case Report
Case Report
The case is that of 83 year-old African American man with hypertension, hepatitis C induced decompensated cirrhosis with ascites, end-stage renal disease (ESRD) on hemodialysis, fluid overload with peripheral edema and chronic hypotension. The patient was referred to the dialysis access center of Pittsburgh, PA for evaluation of his prolonged bleeding from the left upper arm brachial-basilic arterial-venous fistula (BBAVF).
On examination, he was found to be severely hypoxic with oxygen saturation of 80-92 mm Hg. Chest was clear on auscultation. Abdominal examination showed hepatosplenomegaly with ascites. Extremities showed 3+ peripheral edema bilaterally. His chest x-ray showed cardiomegaly with clear lung fields. His laboratory workup showed, WBC of 3.4, RBC 3.69, MCH 31.2, MCHC 32, and platelets 104 K/L. Chemistry showed Na 134, Cl 99, CO2 24, Total protein 7.2 with albumin of 2.9. SGOT was high at 44, vitamin D 42. Laboratory data were also indicative of chronic liver disease with bilirubin of 2.8, INR of 1.2, and albumin of 2.9, and platelet count of 104. Immunology for Hepatitis B Ag was negative, Hepatitis B Ab was 22 H, Hepatitis C Ab was positive. Arterial blood gas analysis showed PaO2 of 54 mmHg while breathing room air.
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001002 Cite this Article
2017-02-22 Research Article
Abstract
Introduction: Endothelial progenitor cells (EPC) are involved in vascular repair and proliferation, contributing to the long-term outcomes of apheretic treatment. Aim of this study was to investigate the relationships between endothelial function, assessed by levels of bone marrow-derived progenitor cells and endothelial response to hyperaemia, and clinical and biohumoral parameters in high vascular risk patients before, immediately after, 24-hours and 72 hours after a single lipid apheresis procedure.
Material and Methods: We evaluated lipid profile, endothelial function and endothelial progenitor cells before (T0), immediately after (T1), 24h after (T2) and 72h after (T3) a lipoprotein apheresis procedure, in 8 consecutive patients [Sex: 62.5% M; Age; 63.29(12), mean, (range) years] with a personal history of acute coronary syndrome, symptomatic peripheral arterial disease and elevated plasma levels of lipoprotein (a) [Lp(a)]. Patients were on regularly weekly or biweekly lipoprotein apheresis, and they were treated with the FDA-approved Heparin-induced Extracorporeal LDL Precipitation (H.E.L.P.) (Plasmat Futura, B.Braun, Melsungen, Germany) technique. PAT values were expressed as the natural logarithm (Ln-RHI, normal values≥0.4) of the reactive hyperaemia index (RHI), which is the parameter automatically calculated by the device.
Results: We found a reduction in the natural logarithm of reactive hyperaemia index (Ln-RHI), assessed immediately after the procedure (0.57±0.21 vs 0.72± 0.29); difference between T2 and T0 was statistically significant (0.43±0.24 vs 0.72±0.29; p=0.006). Reduction in Ln-RHI values was documented in all patients, two subjects showing a Ln-RHI<0.4 at T1, and four at T2. At T3, PAT values were increased significantly (0.91±0.18) in comparison to T1 and T2, showing a median value higher than at T0. Cd34+/Kdr+ and Cd133+/Kdr+ showed a minimum increase in median values at T1, and a higher increase at T2, in comparison to baseline. Differences in Cd34+/133+/Kdr+ values at different times were not statistically significant. A significant reduction in circulating endothelial cells (CEC) count at T2 in comparison to T0 was found (12.00±8.85 vs 23.86±12.39; p=0.024).
Discussion: At 24h and 72h after procedures, we found an improvement in endothelial function, expressed by an increase in PAT values and EPC levels, and by a reduction in CEC.
Material and Methods: We evaluated lipid profile, endothelial function and endothelial progenitor cells before (T0), immediately after (T1), 24h after (T2) and 72h after (T3) a lipoprotein apheresis procedure, in 8 consecutive patients [Sex: 62.5% M; Age; 63.29(12), mean, (range) years] with a personal history of acute coronary syndrome, symptomatic peripheral arterial disease and elevated plasma levels of lipoprotein (a) [Lp(a)]. Patients were on regularly weekly or biweekly lipoprotein apheresis, and they were treated with the FDA-approved Heparin-induced Extracorporeal LDL Precipitation (H.E.L.P.) (Plasmat Futura, B.Braun, Melsungen, Germany) technique. PAT values were expressed as the natural logarithm (Ln-RHI, normal values≥0.4) of the reactive hyperaemia index (RHI), which is the parameter automatically calculated by the device.
Abstract Read Full Article HTML DOI: 10.29328/journal.hjvsm.1001001 Cite this Article
Recent Articles
2021-03-03 Mini Review
Elias Noory*, Tanja Böhme, Ulrich Beschorner and Thomas Zeller
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001014 Citation
2020-07-31 Research Article
Oscar MP Jolobe*
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001013 Citation
2020-04-16 Research Article
Oscar MP Jolobe*
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001012 Citation
2020-04-13 Review Article
Fatih Islamoglu*
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001011 Citation
2020-04-07 Opinion
Francisco R Breijo-Márquez*
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001010 Citation
2019-07-27 Case Report
M Kechida*, W Ben Yahia and W Mnari
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001009 Citation
2019-06-07 Research Article
Mohammed Habib* and Majed Alshounat
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001008 Citation
2018-12-28 Opinion
Awad Magbri* and Mariam El-Magbri
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001007 Citation
2018-12-27 Mini Review
Konstantinos Filis*, Constantinos Zarmakoupis, Fragiska Sigala and George Galyfos
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001006 Citation
2018-09-11 Review Article
KH Kevin Luk* and Koichiro Nandate
Abstract Read Full Article HTML DOI: 10.29328/journal.avm.1001005 Citation